NCT00171119View on ClinicalTrials.gov

A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril

PHASE4TerminatedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

March 31, 2005

Conditions
HypertensionDiabetic Nephropathy
Interventions
DRUG

valsartan

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, Basel

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT00171119 - A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril | Biotech Hunter | Biotech Hunter